Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Mpox // Monkeypox
French (FR)
2022
Clear all
Type of publications
NITAG documentation
(15)
Topics
Regions
Africa
(2)
Europe
(13)
Countries
Belgium
(2)
Burkina Faso
(1)
France
(9)
Luxembourg
(2)
Niger
(1)
Diseases
COVID-19
(12)
Mpox // Monkeypox
(3)
Herpes zoster
(3)
Human papillomavirus (HPV)
(1)
Influenza
(1)
Malaria
(3)
Pertussis
(1)
Pneumococcal disease
(2)
Rotavirus
(1)
Typhoid
(1)
Publication date
2022
(15)
2023
(2)
2021
(36)
2020
(9)
Target population
Available to download in languages
French (FR)
(15)
English (EN)
(80)
Spanish (ES)
(12)
German (DE)
(3)
15 results found
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19: Place of the VLA2001 vaccine
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19: Place of the VidPrevtyn Beta vaccine
2022
∙
Haute Autorité de Santé
Booster vaccine strategy against Covid-19
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19: Place of the Nuvaxovid vaccine in the booster strategy
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19: role of the bivalent Spikevax Original / Omicron BA.4/BA.5 vaccine (mRNA-1273.222)
2022
∙
Haute Autorité de Santé
Booster vaccine strategy against Covid-19 in France
2022
∙
Haute Autorité de Santé
Place of the Cominarty bivalent vaccines against Covid-19 Original/Omicron BA.1 and Original/Omicron BA.4-5
2022
∙
Conseil Supérieur des Maladies Infectieuses
CSMI recommendation on dosage and route of administration Jynneos/Imvanex monkeypox vaccine.
2022
∙
Conseil Supérieur des Maladies Infectieuses
CSMI Recommendation on Monkeypox – Update July 25, 2022
2022
Advice of the NITAG in the context of the administration of a booster dose of COVID-19 vaccine in Niger
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register